FDA Approves Fezolinetant, a First-of-Its-Kind Nonhormonal Drug for Hot Flashes

Veozah is the first drug in a new family of medicines designed to block signals in the brain that cause hot flashes.

Related Keywords

United States ,United Kingdom ,American ,British ,Joann Pinkerton ,Makeba Williams ,Astellas Pharma ,Drug Administration ,Washington University In St ,Women Health Initiative ,University Of Virginia Health In Charlottesville ,American Menopause Society ,Louis School Of Medicine ,Virginia Health ,North American Menopause Society ,Clinical Endocrinology ,British Journal ,Washington University ,Louis School ,Hormone Therapy ,Health Initiative ,